Aerosol testing specialist Proveris Scientific has named Maria L. Smith as Director, Application and Business Development for Proveris Laboratories. Smith has extensive experience in OINDP spray characterization, first at DPT Laboratories and then at Renaissance Lakewood. In addition to business development for the lab, she is expected to “serve as a liaison to regulatory agencies, industry groups, and customers to educate on new technology approaches and how they can be used to support in-vitro in-vivo correlation (IVIVC) and bioequivalence (BE).”
According to the company, the position is a new one created due to the “the rapid growth of the cGMP contract test services and the introduction of new technologies.” Proveris launched cGMP-compliant OINDP testing services in May 2020 and recently added new services for unit dose nasal spray testing.
Proveris Scientific President Chip Leveille said, “Maria’s fourteen years of laboratory experience in spray/particulate science (nasal and oral products) with leading CDMO’s brings a deep understanding of drug development and testing as it pertains to inhalation products. She has extensive knowledge of Proveris systems and particle characterization techniques to develop and characterize aerosol and spray delivered drug devices. We are excited to have Maria on board to further establish and enhance Proveris technologies as critical approaches to drug approval and product release.”
Read the Proveris Scientific press release.
